Business Description
Zenas BioPharma is a clinical-stage company focused on developing new treatments for immune system diseases such as lupus, multiple sclerosis, and IgG4-related disease. Its most advanced drug candidate, obexelimab, works by targeting two specific proteins involved in abnormal immune responses. The company also has several other drug candidates in development aimed at addressing a range of immune-related conditions. Founded in 2019 and based in Waltham, Massachusetts, Zenas BioPharma is working to bring meaningful new options to patients with serious inflammatory diseases.
